Literature DB >> 28082122

Is There Any Difference Between Questionnaires on Pediatric Lower Urinary Tract Dysfunction?

Mesut Altan1, Burak Çitamak1, Ali Cansu Bozaci2, Emin Mammadov1, Hasan Serkan Doğan1, Serdar Tekgül1.   

Abstract

OBJECTIVE: To investigate the diagnostic properties of 3 different scoring systems (Dysfunctional Voiding Symptom Score [DVSS], Dysfunctional Voiding and Incontinence Symptoms Score [DVISS], Incontinence Symptom Index-Pediatric [ISI-P, for children older than 11 years]) that are used to evaluate lower urinary tract symptoms in pediatric population.
MATERIALS AND METHODS: Eighty-four participants were evaluated by detailed history, physical examination, 3 different scoring systems (DVSS, DVISS, ISI-P), ultrasonography, and uroflowmetry. Depending on the tests, cases were stratified as healthy or lower urinary tract symptoms (LUTS) by 2 urologists who were blinded to the questionnaires. Patients were reevaluated by the same tests and questionnaires 3 months after treatment. Diagnostic properties of questionnaires were calculated. Additionally, parents were asked to scale the improvement of symptoms subjectively from 0% to 100% to correlate to each of the three scoring systems.
RESULTS: The mean ages of the normal and the LUTS groups were 9.1 ± 2.6 years and 10.1 ± 2.8 years, respectively (P = .301). Gender (male:female) distribution was 21:21 in the LUTS group and 25:17 in the control group (P = .381). In terms of diagnosis, DVISS has the highest accuracy (sensitivity: 81%, specificity: 97.6%, accuracy: 89%) followed by ISI-P (sensitivity: 55.6%, specificity: 100%, accuracy: 82%) and DVSS (sensitivity: 54.8%, specificity: 97.6%, accuracy: 76%). The similar order was valid for the 23 patients older than 11 years (accuracy for DVISS: 87%, for ISI-P: 82%, and for DVSS: 78%). In terms of response to treatment, all 3 tests showed good correlation with parents' ratings (DVSS: P < .001, DVISS: P = .005, ISI-P: P = .042).
CONCLUSION: Although DVISS had the highest accuracy in distinguishing the patients from healthy controls, all 3 questionnaires seem to be equivalent for the evaluation of response to treatment.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28082122     DOI: 10.1016/j.urology.2016.12.055

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

Review 1.  The Role of Non-invasive Testing in Evaluation and Diagnosis of Pediatric Lower Urinary Tract Dysfunction.

Authors:  Jason P Van Batavia; Andrew J Combs
Journal:  Curr Urol Rep       Date:  2018-04-06       Impact factor: 3.092

2.  Diagnosis and management of bladder bowel dysfunction in children with urinary tract infections: a position statement from the International Children's Continence Society.

Authors:  Stephen Yang; Michael E Chua; Stuart Bauer; Anne Wright; Per Brandström; Piet Hoebeke; Søren Rittig; Mario De Gennaro; Elizabeth Jackson; Eliane Fonseca; Anka Nieuwhof-Leppink; Paul Austin
Journal:  Pediatr Nephrol       Date:  2017-10-03       Impact factor: 3.714

Review 3.  Assessment of pediatric bowel and bladder dysfunction: a critical appraisal of the literature.

Authors:  R Jiang; M S Kelly; J C Routh
Journal:  J Pediatr Urol       Date:  2018-08-28       Impact factor: 1.830

4.  Validation of Serbian Version of Dysfunctional Voiding Symptom Score (DVSS) Questionnaire.

Authors:  Dragana Cirovic; Ivana Petronic; Dejan Nikolic; Tatjana Knezevic; Vojkan Vukadinovic; Polina Pavicevic
Journal:  J Clin Med       Date:  2018-08-14       Impact factor: 4.241

5.  Impact of New vs. Old International Children's Continence Society Standardization on the Classification of Treatment Naïve Enuresis Children at Screening: The Value of Voiding Diaries and Questionnaires.

Authors:  Sevasti Karamaria; Nadejda Ranguelov; Pernille Hansen; Veerle De Boe; Pieter Verleyen; Nathalie Segers; Johan Vande Walle; Lien Dossche; An Bael
Journal:  Front Pediatr       Date:  2022-03-28       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.